Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

Share Price is delayed by 15 minutes
Get Live Data
0.725    0.00 (0.00%)
Bid:
0.70
Ask:
0.75
Spread: 0.05 (7.143%)
Market Cap: £3.24m
THRU Live PriceLast checked at - London Stock Exchange

Intraday Thruvision Grp Share Chart

New product launch

26 Feb 2025 15:16

RNS Number : 5858Y
Thruvision Group PLC
26 February 2025
 

26 February 2025

Thruvision Group plc

Thruvision Launches Next Generation AI Powered 81 Series Passive People Screening Systems

 

Thruvision (AIM: THRU, "Thruvision" or the "Group"), the leading international provider of walk- through security technology, today launches its latest series of products.

 

Thruvision is proud to introduce the 81 Series, the next generation of our world-leading people security screening technology. Designed for use in all markets, the new 81 Series represents the latest evolution in Thruvision's proven people screening technology.

 

The 81 Series features an all-new modular design with integrated touchscreen control, offering a compact, mobile, and unobtrusive solution. This cutting-edge design provides exceptional ergonomics for quick and easy deployment in a wide range of screening operations.

 

Building upon our core principles of treating subjects with respect and privacy, the 81 Series allows for the instant visualisation of threats without the need for pat-downs. Our latest space-grade technology ensures reliability and support for mission-critical operations.

 

The mobile systems enable detection-at-range with a new optional integrated battery pack, providing ultimate flexibility. Capable of screening up to 1,800 people per hour with our WalkTHRU concept of operations, the 81 Series is designed to meet the demands of high-throughput environments.

 

The system detects all materials using our latest and exclusive SmartSCREEN and DynamicDETECT AI software. Available in four models, the 81 Series supports all operation types, from border and entrance security to loss prevention.

 

We invite you to experience the future of people security screening with the Thruvision 81 Series.

 

Further InformationFor more information please visit thruvision.com or email info@thruvision.com

 

81 Series Media Assets

https://drive.google.com/drive/folders/10ybKnqQv_-o0U4dmrRRmUOKsVAGT4zdN?usp=sharing

 

About Thruvision (www.thruvision.com)

Thruvision is the leading developer, manufacturer and supplier of advanced AI-based walk- through security technology internationally. Its technology is deployed in more than 30 countries around the world by government and commercial organisations in a wide range of security situations, where large numbers of people need to be screened quickly, safely and efficiently. Thruvision's patented technology is uniquely capable of detecting concealed objects in real time using advanced AI-based detection algorithms. The Group's offices are near Oxford and Washington DC.

 

Important information

This announcement may include statements that are, or may be deemed to be, 'forward-looking statements' (including words such as 'believe', 'expect', 'estimate', 'intend', 'anticipate' and words of similar meaning). By their nature, forward-looking statements involve risk and uncertainty since they relate to future events and circumstances, and actual results may, and often do, differ materially from any forward-looking statements. Any forward-looking statements in this announcement reflect management's view with respect to future events as at the date of this announcement. Save as required by applicable law, the Company undertakes no obligation to publicly revise any forward-looking statements in this announcement, whether following any change in its expectations or to reflect events or circumstances after the date of this announcement.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAPPUCGPUPAGAQ
Date   Source Headline
4th Apr 20227:00 amRNSYear End Trading Update and Board Changes
1st Apr 20227:01 amRNSBlocklisting update
1st Apr 20227:00 amRNSBlocklisting update
9th Mar 202212:40 pmRNSDirector Share Dealing
21st Feb 20222:07 pmRNSExercise of Sharesave Share Options
25th Jan 20224:06 pmRNSSharesave option grant to Executive Director
24th Dec 20217:00 amRNSDirector Share Dealing
22nd Dec 202112:42 pmRNSHolding(s) in Company
2nd Dec 20216:00 pmRNSDirector Share Dealing
2nd Dec 20212:00 pmRNSInvestor Presentation
1st Dec 202111:36 amRNSDirector Share Dealing
30th Nov 20215:39 pmRNSAward of Share Options to Executive Directors
30th Nov 20211:50 pmRNSDirector Share Dealing
22nd Nov 20217:00 amRNSInterim Results
11th Nov 20217:00 amRNSNotice of Interim Results
27th Oct 20218:52 amRNSBlocklisting application
7th Oct 20217:00 amRNSTrading Update
4th Oct 20219:10 amRNSBlocklisting update
28th Sep 202110:31 amRNSResult of Annual General Meeting
2nd Sep 20217:00 amRNSDirector/PDMR Shareholding
12th Aug 20217:00 amRNSDirector Share Dealing
27th Jul 20211:00 pmRNSDirector/PDMR Shareholding
16th Jul 20213:27 pmRNSReplacement: Holding(s) in Company
15th Jul 20214:43 pmRNSHolding(s) in Company
12th Jul 20217:00 amRNSResults for the Year ended 31 March 2021
9th Jul 20212:34 pmRNSReplacement: Investor Presentation
9th Jul 202111:00 amRNSInvestor Presentation
5th Jul 202112:00 pmRNSNotice of Results
27th May 20211:24 pmRNSDirector Share Dealing
1st Apr 20217:00 amRNSPre-Close Statement
31st Mar 20213:00 pmRNSBlocklisting update
11th Mar 20215:53 pmRNSHolding(s) in Company
10th Mar 20213:33 pmRNSHolding(s) in Company
24th Feb 20217:00 amRNSAppointment of Non-Executive Director
1st Dec 20207:00 amRNSThruvision Investor Presentation
23rd Nov 20207:00 amRNSInterim Results
10th Nov 20207:00 amRNSNotice of Interim Results
9th Oct 202010:18 amRNSHolding(s) in Company
7th Oct 20207:00 amRNSPre-close Trading Update
22nd Sep 202010:31 amRNSResult of Annual General Meeting
18th Sep 20207:00 amRNSContract award announcement
26th Jun 202010:32 amRNSHolding(s) in Company
23rd Jun 20205:21 pmRNSHolding(s) in Company
22nd Jun 20204:24 pmRNSHolding(s) in Company
17th Jun 202011:05 amRNSSecond Price Monitoring Extn
17th Jun 202011:01 amRNSPrice Monitoring Extension
16th Jun 20207:00 amRNSAward of Share Options to Executive Directors
8th Jun 20207:00 amRNSResults for the Year ended 31 March 2020
3rd Jun 20207:22 amRNSNotice of Annual Results
3rd Jun 20207:00 amRNSNotice of Annual Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.